Randomized Study of Metformin and Intensive Lifestyle Intervention on Cancer Incidence over 21 Years of Follow-up in the Diabetes Prevention Program

This study examines both metformin and ILS intervention as primary cancer prevention interventions in people at high risk for type 2 diabetes.

Authors

Anna Bowers
Helen P. Hazuda (ORCID: https://orcid.org/0000-0002-7313-4160)
Jill P. Crandall (ORCID: https://orcid.org/0000-0001-5576-4428)
Marinella Temprosa (ORCID: https://orcid.org/0000-0002-9976-745X)
Richard F. Hamman (ORCID: https://orcid.org/0000-0003-2099-6274)
Philip C. Prorok (ORCID: https://orcid.org/0000-0002-2126-5847)
Brandy M. Heckman‐Stoddard (ORCID: https://orcid.org/0000-0003-1686-7154)
Leslie G. Ford (ORCID: https://orcid.org/0000-0003-2412-8028)
William C. Knowler (ORCID: https://orcid.org/0000-0002-7004-5197)
Mary A. Hoskin (ORCID: https://orcid.org/0000-0002-4964-2763)
Marjorie Perloff (ORCID: https://orcid.org/0000-0003-4244-8367)
Sharon L. Edelstein (ORCID: https://orcid.org/0000-0001-8457-4404)
Dana Dabelea (ORCID: https://orcid.org/0000-0001-9514-8929)
Edward S. Horton